![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 401/06 | |
A61K 31/4709 |
(11) | Number of the document | 2697215 |
(13) | Kind of document | T |
(96) | European patent application number | 12706221.4 |
Date of filing the European patent application | 2012-02-14 | |
(97) | Date of publication of the European application | 2014-02-19 |
(45) | Date of publication and mention of the grant of the patent | 2017-11-22 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2012/052504 |
Date | 2012-02-14 |
(87) | Number | WO 2012/119841 |
Date | 2012-09-13 |
(30) | Number | Date | Country code |
201103837 | 2011-03-07 | GB |
(72) |
BETANCOURT, Aimesther, CA
LEMIEUX, Marc, CA
THIBERT, Roch, CA
|
(73) |
Atopix Therapeutics Limited,
265 Strand, London WC2R 1BH,
GB
|
(54) | AMORPHOUS (5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYL-INDOL-1-YL)-ACETIC ACID |
AMORPHOUS (5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYL-INDOL-1-YL)-ACETIC ACID |